For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official .
: Evaluating whether the viral vector or therapeutic gene could unintentionally be passed on to future generations.
: Assessing the risk of "insertional mutagenesis"—where the therapy might accidentally interfere with the patient's existing DNA.